Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 16, 2022

Primary Completion Date

December 20, 2023

Study Completion Date

December 20, 2023

Conditions
HTLV-1Overactive Bladder Syndrome
Interventions
DRUG

Darifenacin

Anticholinergic drug therapy for OAB treatment - Darifenacin, 15mg/day

DEVICE

Neuromodulation - Sacral nerve stimulation

Neurodyn Portable TENS FES neuromuscular stimulation device in an outpatient clinic. Two self-adhesive electrodes (5x9cm) were used, positioned one in each gluteal region, below the iliac spine to apply low-frequency biphasic current with 10 Hz. Pulse duration of 0.5 milliseconds was applied for 40 minutes with continuous stimulation, 3 times a week, for 20 sessions.

Trial Locations (1)

40110060

Ambulatório de HTLV-1 - Com HUPES, Salvador

All Listed Sponsors
lead

Hospital Universitário Professor Edgard Santos

OTHER